Inhibition of glioma invasion by overexpression of pigment epithelium-derived factor
- 26 March 2004
- journal article
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 11 (5) , 325-332
- https://doi.org/10.1038/sj.cgt.7700675
Abstract
Pigment epithelium-derived factor (PEDF) is a potent inhibitor of angiogenesis and an inducer of neural differentiation. We previously reported the loss of PEDF expression in glioma progression. In this study, we investigated whether PEDF overexpression could suppress glioma growth and invasion. Glioma cell line U251 was stably transfected with a full-length human PEDF expression vector. The expression and release of various cytokines and angiogenic factors into the medium were analyzed by real-time reverse transcription-polymerase chain reaction, enzyme-linked immunosorbent assay, and gelatin zymography. Apoptosis was checked by terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling. Growth inhibition was evaluated by using the in vitro Matrigel invasion. Tumorigenicity was examined in vivo by subcutaneous xenotransplantation into severe combined immunodeficient mice. In U251 cells overexpressing PEDF, thrombospondin-1 protein was upregulated (5.3-fold more), but the production of vascular endothelial growth factor (VEGF) (1.8-fold less) and basic fibroblast growth factor (2.5-fold less) was lower than in cells transfected with the vector only. PEDF also downregulated the production of matrix metalloproteinase-9. Conditioned medium collected from the PEDF-transfected U251 cells showed a significant reduction of VEGF expression. In vitro invasiveness was reduced by approximately 40%. PEDF expression prevented the growth of transfected cells and caused a significant increase in the percentage of cells undergoing apoptosis (50.4% in PEDF-transfected cells). Furthermore, the size of xenotransplants was significantly smaller. In conclusion, PEDF overexpression decreased malignancy, and this might be attributed to the promotion of apoptosis and the regulation of expression of angiogenic effectors. Thus, treatment with PEDF may be useful in patients with malignant gliomas. However, the mechanism of apoptosis induction needs to be investigated.Keywords
This publication has 23 references indexed in Scilit:
- PEDF: A pigment epithelium-derived factor with potent neuronal differentiative activityPublished by Elsevier ,2004
- Loss of pigment epithelium derived factor expression in glioma progressionJournal of Clinical Pathology, 2003
- Autologous transplantation of genetically modified iris pigment epithelial cells: A promising concept for the treatment of age-related macular degeneration and other disorders of the eyeProceedings of the National Academy of Sciences, 2002
- Adeno-associated virus type-2 expression of pigmented epithelium-derived factor or Kringles 1–3 of angiostatin reduce retinal neovascularizationProceedings of the National Academy of Sciences, 2002
- Pigment epithelium-derived factor protects cultured retinal neurons against hydrogen peroxide-induced cell deathJournal of Neuroscience Research, 1999
- Pigment Epithelium-Derived Factor: A Potent Inhibitor of AngiogenesisScience, 1999
- Pigment Epithelium-derived Factor (PEDF) Protects Motor Neurons from Chronic Glutamate-mediated NeurodegenerationJournal of Neuropathology and Experimental Neurology, 1999
- Pigment epithelium-derived factor (PEDF) has direct effects on the metabolism and proliferation of microglia and indirect effects on astrocytesJournal of Neuroscience Research, 1997
- Pigment Epithelium‐Derived Factor Is a Survival Factor for Cerebellar Granule Cells in CultureJournal of Neurochemistry, 1995
- Pigment epithelium-derived factor: neurotrophic activity and identification as a member of the serine protease inhibitor gene family.Proceedings of the National Academy of Sciences, 1993